IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAÏVE EARLY STAGE CLL: PRIMARY ENDPOINT RESULTS OF THE PHASE 3 DOUBLE‐BLIND RANDOMIZED CLL12 TRIAL
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.7_2629
Abstract: RCHOP, HR 0.67 (95% CI 0.441.03), p (one-sided) =0.03 (Figure). The 2-year overall survival was 87% and 80%, respectively. Based on COO, PFS HR for R2CHOP was: 0.68 for ABC, p=0.15, 0.86 for GCB, 0.83… read more here.
Keywords: patients asymptomatic; placebo patients; versus placebo; asymptomatic treatment ... See more keywords
Choto‐san versus placebo for patients with dementia: systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2017 at "Psychogeriatrics"
DOI: 10.1111/psyg.12275
Abstract: Choto‐san is a traditional medicine used for hypertension and headaches in Japan and China. Some studies have shown its effectiveness in the treatment of dementia. The present review aimed to assess the effectiveness and acceptability… read more here.
Keywords: choto san; san versus; placebo patients; versus placebo ... See more keywords